Neurology® Podcast

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Elliot Dimberg interview Dr. Gary Gronseth and Thomas Getchius about the new guidelines on diagnostic evaluation and treatment of trigeminal neuralgia. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week about cranial neuropathies in arterial dissection. The podcast concludes with Dr. Gavin Brown interviewing Dr. Peter Goadsby on the topic of facial pain and headache for the Lesson of the Week segment. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Drs. James Kiely and Christopher Wright interview Dr. Kimford Meador about his paper on pregnancy registries in epilepsy. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week. The podcast concludes with Dr. Chris Boes interviewing Dr. William Landau about his historical papers on Landau-Kleffner syndrome for the Lesson of the Week segment. The participants had nothing to disclose except for Dr. Meador. Dr. Meador disclosures are: Research Support (>$10K): NIH, Eisai, GlaxoSmithKline, Marius, McKnight Brain Institute, Myriad, Neuropace, Pharma, SAM Technology, UCB;

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Mytinger interview Dr. Roderick Duncan about his paper on psychogenic non-epileptic seizures. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week. The podcast concludes with Dr. Mithila Vullaganti interviewing Dr. Michael Goodman about odds ratios for the Lesson of the Week segment. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interview Dr. Stephen Gomperts about his paper on amyloid deposition in Lewy body diseases. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week. The podcast concludes with Dr. Jonathan Bui interviewing Dr. John Carew about PIB imaging methods for the Lesson of the Week segment. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andrew Southerland and Dr. Jennifer Bickel interview Dr. Marcelo Bigal about his paper on the clinical course in migraine. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week. The podcast concludes with Dr. Richard Isaacson interviewing Dr. Stephen D. Silberstein about headache classification for the Lesson of the Week segment. The participants had nothing to disclose except for Dr. Silberstein.Dr. Silberstein is an investigator for the following companies: Abbott, Advanced Bionics, Advance Neur0-Modulation System, AGA, Allergan, AstraZeneca, Endo Pharmaceuticals, GSK, Lilly, Medtronic, Ortho-McNeil, Pfizer, Pozen, ProEthic, Valeant & Vernails, on theadvisory board for the following companies: Allergan, Endo Pharmaceuticals, GSK, Medtronic, Merck, NuPathe, Ortho-McNeil, Pfizer, Pozen & Valeant and speaker for the following companies: AstraZeneca, GSK, Merck, Ortho-McNeil & Pfizer.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Keegan and Dr. Myla Goldman interview Dr. Douglas Goodin about his paper on the use of natalizumab (tysabri) for treatment of multiple sclerosis. In the next segment, Dr. Ryan Overman is reading our e-Pearl of the week. The podcast concludes with Dr. Alexandra Degenhardt interviewing Dr. Neil Lava about practical aspects of natalizumab administration for the Lesson of the Week segment. The participants had nothing to disclose except for Dr. Goodin and Dr. Lava.Dr. Goodin has received honoraria for lectures or as a consultant (directly or indirectly) from Teva Neuroscience, Biogen/Idec, Merck-Serono, Bayer-Schering Healthcare and Berlex Laboratories. Dr. Goodin has received research support from Biogen-Idec, Bayer-Schering and Novartis. Dr. Lava received grants for research in the Sentinel Study.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Drs. Neeraj Kumar and Jason Mackey interview Drs. Sharon Nations and Jaya Trivedi about their paper on denture cream: an unusual source of excess zinc. The podcast concludes with Dr. Amy Kahn interviewing Dr. Neeraj Kumar about heavy metals for the Lesson of the Week segment. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Drs. Juliana Lockman and Alan Ettinger interview Dr. Ley Sander about his paper on drowning in people with epilepsy. The podcast concludes with Dr. Ted Burns interviewing Dr. Sheldon Horowitz about maintenance of certification for the Lesson of the Week segment. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan interviews Drs. Andrew Lees from UK and Regina Katzenschlager from Austria about their trial comparing three initial treatments for Parkinson disease. In this additional segment for this issue, Dr. Overman is introducing a new feature called 'e-pearls' which are brief educational points-pearls-that are often, though not necessarily always, tied to a Neurology article, podcast, or item on the website. The length of each E-Pearl is short and tailored to be read and absorbed within a few minutes. E-pearls are mailed to residents and fellows but in the future we hope to have them available on the website.The podcast concludes with a Clinical Pearl session where Dr. Ryan Overman interviews Dr. S. Nizam Ahmed. Podcast participants had nothing to disclose except for Drs. Lees and Katzenschlager. Dr. Lees received fees for speaking consulting and organizing educational events from Britannia and Novartis. Dr. Katzenschlager received unrestricted grants during first years of this study and fees for speaking and organizing educational events from Britannia and Novartis.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael Benatar and Dr. Bud Rowland interview Dr. Don Sanders about his papers describing the results of two recently completed RCT of cellcept in myasthenia gravis. The podcast concludes with Dr. Ted Burns interviewing Dr. Gary Cutter about outcome measures for the Lesson of the Week segment. The participants had nothing to disclose.